US20100068310A1 - External composition for skin containing scrophularia buergeriana miq. extract and the use thereof for the skin moisturizing cosmetics - Google Patents
External composition for skin containing scrophularia buergeriana miq. extract and the use thereof for the skin moisturizing cosmetics Download PDFInfo
- Publication number
- US20100068310A1 US20100068310A1 US12/528,774 US52877407A US2010068310A1 US 20100068310 A1 US20100068310 A1 US 20100068310A1 US 52877407 A US52877407 A US 52877407A US 2010068310 A1 US2010068310 A1 US 2010068310A1
- Authority
- US
- United States
- Prior art keywords
- extract
- skin
- poria cocos
- scrophularia buergeriana
- buergeriana miq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Definitions
- the present invention relates to a skin external composition for alleviating dry skin symptoms, which contains an extract of Scrophularia buergeriana Miq. as a main component and further contains an extract of Poria cocos Wolf, as well as the use thereof for skin-moisturizing cosmetics. More specifically, the present invention related to a skin external composition comprising an extract of Scrophularia buergeriana Miq. and an extract of Poria cocos Wolf, which, when applied on the skin, can normally restore and maintain the differentiation of skin keratinocytes, and thus can prevent or alleviate dry skin symptoms, atopic symptoms and contact dermatitis, which occur due to incomplete epidermal differentiation, as well as the use thereof for skin-moisturizing cosmetics.
- the most important functions of the epidermis that is the outermost layer of the skin are protective functions to protect the body from various external stimuli (physical and chemical stimuli, including chemical substances, pollutants, dry environments and UV rays) and to prevent the excessive evaporation of water in the body through the skin.
- Such protective functions can be maintained only when the stratum corneum (horny layer) consisting of keratinocytes is normally formed.
- stratum corneum that is the outermost layer of the epidermis is formed from keratinocytes and consists of differentiated keratinocytes and lipids surrounding the keratinocyts (J. Invest. Dermatol. 1983; 80: 44-49).
- Keratinocytes are characteristic cells formed through a process in which basal cells continuously proliferating in the lowest layer of the epidermis undergo a stepwise change in the shape and function thereof and rise to the surface of the skin. After the passage of a given period of time, dead keratinocytes are removed from the skin and replaced with new keratinocytes, and such a repeated process is called the “differentiation or keratinization of epidermal cells”. During the keratinization process, keratinocytes produce intracellular lipids (ceramide, cholesterol and fatty acid) with natural moisturizing factors (NMF) while forming the stratum corneum, such that the stratum corneum has firmness and flexibility to function as a skin barrier.
- ceramide, cholesterol and fatty acid with natural moisturizing factors (NMF)
- the stratum corneum easily loses its function due to living habitual factors, such as excessive washing or bathing, environmental factors, such as dry atmospheres or pollutants, and endogenous diseases, such as atopic skins or senile skins.
- living habitual factors such as excessive washing or bathing
- environmental factors such as dry atmospheres or pollutants
- endogenous diseases such as atopic skins or senile skins.
- persons suffering from dry skin symptoms due to various factors, and various disorders caused by the dry skin symptoms have recently gradually increased.
- many studies focused on supplying water from an external source or on preventing the loss of water from the body have been conducted, and in fact, various kinds of moisturizers having water-holding capacity have been developed and mainly used in the cosmetic field.
- Such abnormal division and differentiation of epidermal cells result in various skin diseases, including dry skin (xerosis), atopy and psoriasis.
- skin diseases including dry skin (xerosis), atopy and psoriasis.
- moisturizers having a water-holding function in themselves are used, such skin diseases can be slightly alleviated, but it is difficult to expect the fundamental treatment of the skin diseases.
- the present inventors have developed a substance regulating the differentiation of epidermal cells and have attempted the developed substance on the skin to induce the normal production and removal of the stratum corneum and enhance the production and maintenance of natural moisturizing factors in the stratum corneum of the skin so as to fundamentally prevent or treat dry skin diseases, including dry skin (xerosis) and atopy caused thereby.
- the present inventors have conducted studies associated with the differentiation of epidermal cells and, as a result, have found that an extract of Scrophularia buergeriana Miq. and an extract of Poria cocos Wolf function to promote the differentiation of keratinocytes and, in addition, promote the synthesis of the intracellular lipid ceramide and activate peroxisome proliferator activated receptor-alpha (PPAR- ⁇ ), a kind of nuclear hormone receptor, which promotes the differentiation of keratinocytes, inhibits the proliferation of keratinocytes, increases the synthesis of intracellular lipids, and through such findings, the present inventors could further confirm the effects of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract. Also, the present inventors have found that, when the extracts are applied to the animal skin in the form of a skin external preparation, they enhance the skin barrier function, thereby completing the present invention.
- PPAR- ⁇ peroxisome proliferator activated receptor-alpha
- Another object of the present invention is to provide an external composition for skin moisturization, which can increase the water-holding capacity of the skin through the effects of the extracts to increase the flexibility and firmness of the skin, thus allowing the skin to smoothly perform the original protective function thereof, and, in addition, can reduce the formation of fine wrinkles caused by skin drying, thus prevent or treat dry skin diseases, such as dry skin or atopy.
- the present invention provides an external composition for skin moisturization, which contains an extract of Scrophularia buergeriana Miq. as an active ingredient.
- composition according to the present invention may further contain, in addition to the Scrophularia buergeriana Miq. extract, an extract of Poria cocos Wolf.
- the external composition for skin moisturization preferably contains 0.0001-30 wt % of the Scrophularia buergeriana Miq. extract.
- the external composition for skin moisturization is preferably used to enhance the skin barrier function, promote the differentiation of keratinocytes, promote the production of ceramide or activate PPAR- ⁇ .
- the present invention provides the use of the external composition, containing the Scrophularia buergeriana Miq. extract as an active ingredient, for skin-moisturizing cosmetics.
- Scrophularia buergeriana Miq. which is used in the present invention, is a perennial plant belonging to the family Scrophulariaceae, and is distributed in Korea, China, Japan, etc., and the root thereof is used as a medicinal material in Chinese medicine. It contains, as main components, scrophularine, phytosterol and phytosterine and, in addition, contains saccharides, essential oils, fatty acids, etc. Scrophularia buergeriana Miq. has the effects of lowering fever and improving cardiac functions, and thus it is used for sore throat, tonsillitis, conjunctivitis, lymphadenitis and the like and is effective against various diseases with fever.
- Poria cocos Wolf which is used in the present invention, is a member of the family Polyporaceae and lives on the root of pine trees. It is in the form of a fungal mass having a diameter of about 30-50 cm, the outside thereof is rough like the pine tree bark, and the inside thereof is white or pink in color. Poria cocos Wolf, the inside of which is white in color, lives on the root of pine trees, and Poria cocos Wolf, the inside of which is pink in color, lives on the root of Japanese pine tree.
- Poria cocos Wolf The triterpene component of Poria cocos Wolf was reported to have anti-vomiting and anti-inflammatory effects, etc., and the sclerotium of Poria cocos Wolf contains ⁇ -pachyman in an amount corresponding to about 93% of the dry weight of Poria cocos Wolf. It also contains triterpenoid compounds, pachymic acid, tumulosic acid, 3 ⁇ -hydroxylanosta-7,9 and 24-triene-2-acid and, in addition, contains chitin, sterol, lecithin, adenine, histidine, choline, lipase, proteinase, etc. Also, Poria cocos Wolf has been used as a tonic for a long time.
- Poria cocos Wolf has a diuretic effect, a blood glucose-lowering effect and a sedative effect, and it is known to have an immune-activating effect. Also, it is known to be effective for women's diseases.
- the Scrophularia buergeriana Miq. extract or the combination of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract is preferably contained in an amount of 0.0001-30 wt % based on the total weight of the composition. If the content of the extract is less than 0.0001 wt %, the extract cannot provide the skin-moisturizing effect, the effect of enhancing the skin barrier function, and the effect of inducing the differentiation of skin keratinocytes, and if the content exceeds 30 wt %, the increase in the content will not lead to a significant increase in the effect of the extract.
- the external composition for skin moisturization according to the present invention can be provided as a cosmetic composition or a pharmaceutical composition, and the formulation of the inventive composition will now be described in further detail.
- the cosmetic composition according to the present invention may contain, in addition to the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract, other components, which can increase the main effects of the present invention, as long as the main effects of the present invention are not adversely affected.
- Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract of the present invention are preferably formulated into cosmetic preparations and applied on the skin, they may also be prepared in the form of conventional external preparations.
- a cosmetic composition containing the inventive composition containing the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract may be in the form of a solution, an emulsion or a viscous mixture.
- the cosmetic composition of the present invention can be used in various cosmetics in order to provide the effect of moisturizing the skin, the effect of enhancing the skin barrier function or the effect of inducing the differentiation of skin keratinocytes.
- Examples of products, to which the composition of the present invention include cosmetics, such as creams, lotions and skin lotions, cleansing foams, face cleansers, soaps, beauty solutions, etc.
- the formulation of the cosmetic composition of the present invention may include skin lotion, astringent lotion, milk lotion, nourishing cream, massage cream, essence, eye cream, eye essence, pack, gel, powder, makeup base, foundation, ointment, patch, beauty solution, cleansing foam, cleansing cream, cleansing water, body lotion, body cream, body oil, body essence, shampoo, rinse, body cleanser, soap, hair dye, spray and the like.
- the pharmaceutical composition according to the present invention may further contain suitable carriers, excipients or diluents, which are conventionally used in the preparation of pharmaceutical compositions.
- the inventive pharmaceutical composition containing the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract can be formulated into various preparations suitable for pharmaceutical application, including external preparations, such as ointments, gels, creams, patches or sprays, according to conventional methods.
- external preparations such as ointments, gels, creams, patches or sprays, according to conventional methods.
- Each of such preparations may contain various bases and additives, which are required and suitable for the formulation thereof, and the kinds and amounts of these components can be easily selected by those skilled in the art.
- each of the preparations varies depending on the age, sex, weight and disease condition of a patient and the mode of administration, but each of the preparations is preferably applied at a dose of 1.0-3.0 ml/day 1-5 times a day for at least one month.
- the Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract of the present invention have little or no toxicity and side effects, and thus can be safely used for preventive purposes for a long period of time.
- the external composition for skin moisturization according to the present invention is characterized in that it contains, in addition to the Scrophularia buergeriana Miq. extract, the Poria cocos Wolf extract.
- the skin external composition of the present invention can normally induce keratinocytes, which are backbone components forming the stratum corneum and the skin barrier, such that the skin can be protected from external physical stimuli.
- the external composition of the present invention can promote the biosynthesis of lipids, which surround keratinocytes to form the skin barrier, such that the skin barrier can be enhanced. By virtue of such effects, the inventive skin external composition containing said Scrophularia buergeriana Miq.
- Poria cocos Wolf extract can be advantageously used as a cosmetic or pharmaceutical composition for skin moisturization in order to prevent or alleviate dry skin, atpoic dermatitis, contact dermatitis or psoriasis, which occur due to the incomplete differentiation of the epidermis, and to enhance the skin barrier function and induce the differentiation of skin keratinocytes.
- a Scrophularia buergeriana Miq. extract and a Poria cocos Wolf extract were prepared by extracting effective components from each of freeze-dried Scrophularia buergeriana Miq. and Poria cocos Wolf using each of extraction solvents and concentrating and drying the extracts.
- anhydrous or hydrated ethanol and methanol extracts were dissolved in a suitable amount of a mixed solvent of water with ethyl acetate, butanol or hexane and left to stand to separate it into layers, and then the upper layer was separated.
- the extracts thus obtained were concentrated using a vacuum evaporator and dried, and the dried extracts were dissolved in a solvent, such as water, ethanol or 1,3-butyleneglycol.
- Dried powdery Poria cocos Wolf was also extracted in the same manner as in the above-described method for extracting Scrophularia buergeriana Miq. Specifically, water, lower alcohol, such as methanol or ethanol, ethyl acetate or n-hexane, was added to dried powdery Poria cocos Wolf in an amount of 1-15 times the weight of the Poria cocos Wolf, and the added Poria cocos Wolf was extracted by heating at 50-100° C. for 3-24 ours or immersed in the solvent at 4-25° C. for 3-4 to extract effective components therefrom.
- lower alcohol such as methanol or ethanol, ethyl acetate or n-hexane
- anhydrous or hydrated ethanol and methanol extracts were dissolved in a suitable amount of a mixed solvent of water with ethyl acetate, butanol or hexane and left to stand to separate it into layers, and then the upper layer was separated.
- the extracts thus obtained were concentrated using a vacuum evaporator and dried, and the dried extracts were dissolved in a solvent, such as water, ethanol or 1,3-butyleneglycol.
- the lower water layer was added to and shaken in a 2-fold weight of an ethyl acetate solvent and was then left to stand at room temperature for one day to separate it into layers.
- the upper ethylacetate layer was separated and concentrated in a vacuum evaporator, thus obtaining an ethylacetate fraction of each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts.
- the lower water layer obtained in the process of obtaining the ethylacetate fraction in Reference Example 4, was added to a 2-fold weight of butanol and treated in the same manner as in Reference Example 4, thus obtaining a butanol fraction of each of the extracts.
- Each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts or each of the concentrated Scrophularia buergeriana Miq. and Poria cocos Wolf extracts was dissolved in water at a concentration of 30% (w/w), 1,3-butyleneglycol at a concentration at a concentration of 5% (w/w) or ethanol at a concentration of 10% (w/w).
- Each of the solutions was added to cosmetic formulations, such as skin lotion, milk lotion, essence or pack.
- Example 3 the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract were mixed with each other at a ratio of 1:1.
- tests were carried out using the following two methods: (1) a method of measuring the amount of cornified envelops (CE), formed in the differentiation of keratinocytes, using absorbance; and (2) a method of measuring the amount of cornified envelops (CE), formed in the differentiation of keratinocytes, using an isotope.
- CE cornified envelops
- a group treated with low calcium (0.03 mM) and a group treated with high calcium (1.2 mM) were used as a negative control group and a positive control group, respectively, and the results of the test performed by adding the test materials to a low concentration of calcium are shown in Table 2 and FIG. 1.
- the cells were harvested and washed with PBS (phosphate buffered saline), and then 500 ⁇ l of PBS, containing 2% SDS (sodium dodecyl sulfate) and 20 mM DTT (dithiothreitol), was added thereto, and the cell solution was pipetted. Then, 100 ⁇ l of the cell solution was dispensed into each scintillation vial, 2.5 ml of a cocktail solution was added thereto, and the radioactivity of the cell solution was measured with a liquid scintillation counter (LSC) to determine the total protein amount. Based on the determined total protein amount, the corresponding amount of each of the test materials was filtered through a 25-mm filter.
- PBS phosphate buffered saline
- SDS sodium dodecyl sulfate
- DTT dithiothreitol
- Test material water extract of Differentiation ability Differentiation ability (%) Scrophularia buergeriana Miq. (%) of keratinocytes of human skin cell line Control groups Low Ca 2+ (0.03 mM) 100 100 High Ca 2+ (1.2 mM) 210 224 Groups treated 1.0 ppm Scrophularia 118 124 with test material buergeriana Miq. 1.0 ppm Poria cocos Wolf 118 120 1.0 ppm Scrophularia 128 136 buergeriana Miq./ Poria cocos Wolf mixture
- the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts according to the present invention promoted the differentiation of both the keratinocytes and the human skin cell line. Also, it could be observed that the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more effective than the use of the Scrophularia buergeriana Miq. extract alone.
- the human skin cell line was placed in each well of a 96-well cell culture plate at a concentration of 5 ⁇ 10 4 cells/well and allowed to adhere to the bottom for 24 hours.
- the adhered cell line was treated with ach of the test materials, and after 2 days, the media were removed, and the cells were stored in a refrigerator at ⁇ 20° C.
- the cells were left to stand to evaporate the organic solvent and were blocked using 1% fetal bovine albumin, transglutaminase (primary antibody) and HRP (horseradish peroxidase) anti-mouse secondary antibody, and o-phenyldiamine (OPD) was added to develop the color of the cells.
- the expression level of transglutaminase in the cells was determined by measuring absorbance at 490 nm, and the correction of the measurement was carried out by measuring the background at 630 nm.
- a group treated with low calcium (0.03 mM) and a group treated with high calcium (1.2 mM) were used as a negative control group and a positive control group, respectively, and the results of the test performed by adding the test materials to a low concentration of calcium are shown in Table 3 and FIG. 3.
- the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts according to the present invention showed an increase in transglutaminase expression level of more than two times that of the negative control group and showed a significant increase in transglutaminase expression level compared to the negative control group.
- the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts according to the present invention increased the expression of transglutaminase.
- the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more, effective than the use of the Scrophularia buergeriana Miq. extract alone.
- the composition of the test material consisted of 0.5% of Carbopol ETD 2020, 0.45% of TEA 0.45%, 5% test material and the balance of deionized water.
- a region having a size corresponding to the size of a 50-ml polypropylene conical tube was marked, and then 20 ⁇ l of each of control groups, the Scrophularia buergeriana Miq. extract and the Scrophularia buergeriana Miq.
- extract/ Poria cocos Wolf extract mixture was applied on the subjects.
- the subjects were divided into two groups, lipids were extracted from the subjects at day 3 and day 11 in the following manner, and the extracted lipid were analyzed.
- the forearm was washed with service water, and then subjected to tape stripping one time with Scotch® 810 Magic tape. Then, 1 ml of a mixture of cyclohexane/ethanol (4:1) was added to the forearm using a 50-ml cut polypropylene conical tube as a reservoir and shaken for about 1 minute, and was then transferred into a fresh tube.
- Monkey kidney epithelial cell line CV-1 (ATCC CCL 70) was subcultured in a DMEM (Dulbecco's Modified Eagle Medium) containing charcol/dextran-treated 10% fetal bovine serum. A phenol red-free medium was used to avoid the effect of estrogen upon phenol red.
- DMEM Dulbecco's Modified Eagle Medium
- plasmids used were plasmids having PPRE (PPARs responsive element) as a promoter, followed by firefly luciferase genes as a reporter, the PPRE being activated by PPAR- (gene-containing PPAR- and ligand-bound PPAR-) bound next to the universal promoter expressed under general culture conditions, and a reference plasmid to which renilla luciferase genes were bound.
- PPRE PPARs responsive element
- CV-I cells were plated on a 24-well microtiter plate at a concentration of 5 ⁇ 10 4 cells per well and cultured for 24 hours. Then, the above three types of plasmid genes were subjected to transient transfection. After 24 hours of culture, the plate was washed with 1 ⁇ PBS (Phosphate Buffered Saline) and treated with ligand candidates at various concentrations. After 24 hours of further culture, the plate was washed with 1 ⁇ PBS and the cells were lyzed with 1 ⁇ PLB (Passive Lysis Buffer) and measured for luciferase activity using the Dual-Luciferase® Reporter Assay System kit.
- 1 ⁇ PBS Phosphate Buffered Saline
- ligand candidates at various concentrations.
- 1 ⁇ PLB Passive Lysis Buffer
- the positive control was Wy-14,643 which was known to be the most potent PPAR- ⁇ ligand
- the negative controls were ethanol, which was used to dissolve the samples, and an untreated group.
- FIG. 7 As shown in FIG. 7, the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more effective in activating PPAR- ⁇ than the use of the Scrophularia buergeriana Miq. extract alone.
- the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract showed very effects on the promotion of skin cell differentiation, the inhibition of skin cell proliferation, the proliferation of keratinocytes, the recovery of impaired skin barrier function and the increase in skin-moisturizing capacity.
- formulation examples of the inventive composition will be described, but these formulation examples are illustrative only, and the scope of the present invention is not limited thereto.
- the herbal medicinal extract in the formulation examples is any one of the extracts of Examples 1 to 3.
- Herbal medicinal extract 1.00(%)
- Oil and fat suitable amount
- the total amount was made 100% with purified water.
- Soap was prepared according to the above composition ration.
- Herbal medicinal extract 3.00(%)
- Citric acid 0.05
- Licorice root extract 0.20
- the total amount was made 100% with purified water.
- Herbal medicinal extract 1.00(%)
- Polyethyleneglycol monostearate 2.00
- Glycosphingolipid 1.00
- the total amount was made 100% with purified water.
- Cream was prepared according to the above composition ratio (%).
- Herbal medicinal extract 5.00(%)
- the total amount was made 100% with purified water.
- Cosmetic pack was prepared according to the above composition ratio (%).
- Herbal medicinal extract 2.00(%)
- Hydroxyethylene cellulose (2% aqueous solution): 12.00
- Xanthan gum (2% aqueous solution): 2.00
- the total amount was made 100% with purified water.
- composition of the present invention can normally restore and maintain the differentiation of skin keratinocytes, and thus can prevent or alleviate dry skin symptoms, atopic symptoms and contact dermatitis, which occur due to incomplete epidermal differentiation.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
- The present invention relates to a skin external composition for alleviating dry skin symptoms, which contains an extract of Scrophularia buergeriana Miq. as a main component and further contains an extract of Poria cocos Wolf, as well as the use thereof for skin-moisturizing cosmetics. More specifically, the present invention related to a skin external composition comprising an extract of Scrophularia buergeriana Miq. and an extract of Poria cocos Wolf, which, when applied on the skin, can normally restore and maintain the differentiation of skin keratinocytes, and thus can prevent or alleviate dry skin symptoms, atopic symptoms and contact dermatitis, which occur due to incomplete epidermal differentiation, as well as the use thereof for skin-moisturizing cosmetics.
- The most important functions of the epidermis that is the outermost layer of the skin are protective functions to protect the body from various external stimuli (physical and chemical stimuli, including chemical substances, pollutants, dry environments and UV rays) and to prevent the excessive evaporation of water in the body through the skin. Such protective functions can be maintained only when the stratum corneum (horny layer) consisting of keratinocytes is normally formed. The stratum corneum that is the outermost layer of the epidermis is formed from keratinocytes and consists of differentiated keratinocytes and lipids surrounding the keratinocyts (J. Invest. Dermatol. 1983; 80: 44-49). Keratinocytes are characteristic cells formed through a process in which basal cells continuously proliferating in the lowest layer of the epidermis undergo a stepwise change in the shape and function thereof and rise to the surface of the skin. After the passage of a given period of time, dead keratinocytes are removed from the skin and replaced with new keratinocytes, and such a repeated process is called the “differentiation or keratinization of epidermal cells”. During the keratinization process, keratinocytes produce intracellular lipids (ceramide, cholesterol and fatty acid) with natural moisturizing factors (NMF) while forming the stratum corneum, such that the stratum corneum has firmness and flexibility to function as a skin barrier.
- However, the stratum corneum easily loses its function due to living habitual factors, such as excessive washing or bathing, environmental factors, such as dry atmospheres or pollutants, and endogenous diseases, such as atopic skins or senile skins. In fact, persons suffering from dry skin symptoms due to various factors, and various disorders caused by the dry skin symptoms, have recently gradually increased. Thus, in order to maintain the skin water content at a suitable level, many studies focused on supplying water from an external source or on preventing the loss of water from the body have been conducted, and in fact, various kinds of moisturizers having water-holding capacity have been developed and mainly used in the cosmetic field.
- However, as environmental factors harmful to the human body gradually increase and the aged population increases rapidly, persons having skin conditions, in which the turnover rate of the stratum corneum decreases, the lipid synthesizing ability of keratinocytes decreases, or the normal division, growth and differentiation of cells in the epidermis do not become smooth, so that the amount of moisturizing factors and lipids in the stratum corneum is reduced, and thus the normal function of the stratum corneum is not maintained, that is, the skin barrier function is impaired, are gradually increasing.
- Such abnormal division and differentiation of epidermal cells result in various skin diseases, including dry skin (xerosis), atopy and psoriasis. When moisturizers having a water-holding function in themselves are used, such skin diseases can be slightly alleviated, but it is difficult to expect the fundamental treatment of the skin diseases.
- Accordingly, the present inventors have developed a substance regulating the differentiation of epidermal cells and have attempted the developed substance on the skin to induce the normal production and removal of the stratum corneum and enhance the production and maintenance of natural moisturizing factors in the stratum corneum of the skin so as to fundamentally prevent or treat dry skin diseases, including dry skin (xerosis) and atopy caused thereby.
- The present inventors have conducted studies associated with the differentiation of epidermal cells and, as a result, have found that an extract of Scrophularia buergeriana Miq. and an extract of Poria cocos Wolf function to promote the differentiation of keratinocytes and, in addition, promote the synthesis of the intracellular lipid ceramide and activate peroxisome proliferator activated receptor-alpha (PPAR-α), a kind of nuclear hormone receptor, which promotes the differentiation of keratinocytes, inhibits the proliferation of keratinocytes, increases the synthesis of intracellular lipids, and through such findings, the present inventors could further confirm the effects of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract. Also, the present inventors have found that, when the extracts are applied to the animal skin in the form of a skin external preparation, they enhance the skin barrier function, thereby completing the present invention.
- Therefore, it is an object of the present invention to promote the normal differentiation of keratinocytes in the epidermis to induce the following effects: (1) the effect of normally inducing keratinocytes, which are backbone components forming the stratum corneum and the skin barrier, such that the skin can be protected from external physical stimuli; and (2) the effect of promoting the biosynthesis of lipids, which surround keratinocytes to form the skin barrier, such that the skin barrier can be enhanced. Another object of the present invention is to provide an external composition for skin moisturization, which can increase the water-holding capacity of the skin through the effects of the extracts to increase the flexibility and firmness of the skin, thus allowing the skin to smoothly perform the original protective function thereof, and, in addition, can reduce the formation of fine wrinkles caused by skin drying, thus prevent or treat dry skin diseases, such as dry skin or atopy.
- To achieve the above objects, the present invention provides an external composition for skin moisturization, which contains an extract of Scrophularia buergeriana Miq. as an active ingredient.
- The composition according to the present invention may further contain, in addition to the Scrophularia buergeriana Miq. extract, an extract of Poria cocos Wolf.
- The external composition for skin moisturization preferably contains 0.0001-30 wt % of the Scrophularia buergeriana Miq. extract.
- Also, the external composition for skin moisturization is preferably used to enhance the skin barrier function, promote the differentiation of keratinocytes, promote the production of ceramide or activate PPAR-α.
- In addition, the present invention provides the use of the external composition, containing the Scrophularia buergeriana Miq. extract as an active ingredient, for skin-moisturizing cosmetics.
- Hereinafter, the present invention will be described in detail.
- Scrophularia buergeriana Miq., which is used in the present invention, is a perennial plant belonging to the family Scrophulariaceae, and is distributed in Korea, China, Japan, etc., and the root thereof is used as a medicinal material in Chinese medicine. It contains, as main components, scrophularine, phytosterol and phytosterine and, in addition, contains saccharides, essential oils, fatty acids, etc. Scrophularia buergeriana Miq. has the effects of lowering fever and improving cardiac functions, and thus it is used for sore throat, tonsillitis, conjunctivitis, lymphadenitis and the like and is effective against various diseases with fever.
- Poria cocos Wolf, which is used in the present invention, is a member of the family Polyporaceae and lives on the root of pine trees. It is in the form of a fungal mass having a diameter of about 30-50 cm, the outside thereof is rough like the pine tree bark, and the inside thereof is white or pink in color. Poria cocos Wolf, the inside of which is white in color, lives on the root of pine trees, and Poria cocos Wolf, the inside of which is pink in color, lives on the root of Japanese pine tree. The triterpene component of Poria cocos Wolf was reported to have anti-vomiting and anti-inflammatory effects, etc., and the sclerotium of Poria cocos Wolf contains β-pachyman in an amount corresponding to about 93% of the dry weight of Poria cocos Wolf. It also contains triterpenoid compounds, pachymic acid, tumulosic acid, 3β-hydroxylanosta-7,9 and 24-triene-2-acid and, in addition, contains chitin, sterol, lecithin, adenine, histidine, choline, lipase, proteinase, etc. Also, Poria cocos Wolf has been used as a tonic for a long time. The results of pharmacological tests revealed that Poria cocos Wolf has a diuretic effect, a blood glucose-lowering effect and a sedative effect, and it is known to have an immune-activating effect. Also, it is known to be effective for women's diseases.
- In the external composition for skin moisturization according to the present invention, the Scrophularia buergeriana Miq. extract or the combination of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract is preferably contained in an amount of 0.0001-30 wt % based on the total weight of the composition. If the content of the extract is less than 0.0001 wt %, the extract cannot provide the skin-moisturizing effect, the effect of enhancing the skin barrier function, and the effect of inducing the differentiation of skin keratinocytes, and if the content exceeds 30 wt %, the increase in the content will not lead to a significant increase in the effect of the extract.
- The external composition for skin moisturization according to the present invention can be provided as a cosmetic composition or a pharmaceutical composition, and the formulation of the inventive composition will now be described in further detail.
- The cosmetic composition according to the present invention may contain, in addition to the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract, other components, which can increase the main effects of the present invention, as long as the main effects of the present invention are not adversely affected.
- Although the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract of the present invention are preferably formulated into cosmetic preparations and applied on the skin, they may also be prepared in the form of conventional external preparations.
- A cosmetic composition containing the inventive composition containing the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract may be in the form of a solution, an emulsion or a viscous mixture.
- The cosmetic composition of the present invention can be used in various cosmetics in order to provide the effect of moisturizing the skin, the effect of enhancing the skin barrier function or the effect of inducing the differentiation of skin keratinocytes. Examples of products, to which the composition of the present invention, include cosmetics, such as creams, lotions and skin lotions, cleansing foams, face cleansers, soaps, beauty solutions, etc.
- Specifically, there is no particular limitation on the formulation of the cosmetic composition of the present invention, and examples of the formulation of the cosmetic composition may include skin lotion, astringent lotion, milk lotion, nourishing cream, massage cream, essence, eye cream, eye essence, pack, gel, powder, makeup base, foundation, ointment, patch, beauty solution, cleansing foam, cleansing cream, cleansing water, body lotion, body cream, body oil, body essence, shampoo, rinse, body cleanser, soap, hair dye, spray and the like.
- In a cosmetic composition having each formulation, other components in addition to the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract can be suitably selected without difficulty by those skilled in the art depending on the formulation or intended use of the cosmetic composition.
- The pharmaceutical composition according to the present invention may further contain suitable carriers, excipients or diluents, which are conventionally used in the preparation of pharmaceutical compositions.
- The inventive pharmaceutical composition containing the above-described Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract can be formulated into various preparations suitable for pharmaceutical application, including external preparations, such as ointments, gels, creams, patches or sprays, according to conventional methods. Each of such preparations may contain various bases and additives, which are required and suitable for the formulation thereof, and the kinds and amounts of these components can be easily selected by those skilled in the art.
- The dose of each of the preparations varies depending on the age, sex, weight and disease condition of a patient and the mode of administration, but each of the preparations is preferably applied at a dose of 1.0-3.0 ml/day 1-5 times a day for at least one month.
- Meanwhile, the Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract of the present invention have little or no toxicity and side effects, and thus can be safely used for preventive purposes for a long period of time.
- The external composition for skin moisturization according to the present invention is characterized in that it contains, in addition to the Scrophularia buergeriana Miq. extract, the Poria cocos Wolf extract. The skin external composition of the present invention can normally induce keratinocytes, which are backbone components forming the stratum corneum and the skin barrier, such that the skin can be protected from external physical stimuli. Also, the external composition of the present invention can promote the biosynthesis of lipids, which surround keratinocytes to form the skin barrier, such that the skin barrier can be enhanced. By virtue of such effects, the inventive skin external composition containing said Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract can be advantageously used as a cosmetic or pharmaceutical composition for skin moisturization in order to prevent or alleviate dry skin, atpoic dermatitis, contact dermatitis or psoriasis, which occur due to the incomplete differentiation of the epidermis, and to enhance the skin barrier function and induce the differentiation of skin keratinocytes.
- Hereinafter, the present invention will be described in further detail with reference to examples and test examples, but the scope of the present invention are not limited only to these examples.
- As described in Reference Examples 1 to 6 of the present invention, a Scrophularia buergeriana Miq. extract and a Poria cocos Wolf extract were prepared by extracting effective components from each of freeze-dried Scrophularia buergeriana Miq. and Poria cocos Wolf using each of extraction solvents and concentrating and drying the extracts.
- Water, lower alcohol, such as methanol or ethanol, ethyl acetate or n-hexane, was added to Scrophularia buergeriana Miq. in an amount of 1-15 times the weight of the Scrophularia buergeriana Miq. Then, the Scrophularia buergeriana Miq. was extracted by heating at 50-100° C. for 3-24 hours or immersed in the solvent at 4-25° C. for 3-4 days to extract effective components therefrom. Also, the anhydrous or hydrated ethanol and methanol extracts were dissolved in a suitable amount of a mixed solvent of water with ethyl acetate, butanol or hexane and left to stand to separate it into layers, and then the upper layer was separated. The extracts thus obtained were concentrated using a vacuum evaporator and dried, and the dried extracts were dissolved in a solvent, such as water, ethanol or 1,3-butyleneglycol.
- Dried powdery Poria cocos Wolf was also extracted in the same manner as in the above-described method for extracting Scrophularia buergeriana Miq. Specifically, water, lower alcohol, such as methanol or ethanol, ethyl acetate or n-hexane, was added to dried powdery Poria cocos Wolf in an amount of 1-15 times the weight of the Poria cocos Wolf, and the added Poria cocos Wolf was extracted by heating at 50-100° C. for 3-24 ours or immersed in the solvent at 4-25° C. for 3-4 to extract effective components therefrom. Also, the anhydrous or hydrated ethanol and methanol extracts were dissolved in a suitable amount of a mixed solvent of water with ethyl acetate, butanol or hexane and left to stand to separate it into layers, and then the upper layer was separated. The extracts thus obtained were concentrated using a vacuum evaporator and dried, and the dried extracts were dissolved in a solvent, such as water, ethanol or 1,3-butyleneglycol.
- Because the extract obtained through the extraction method of Reference Example 1 among Reference Examples below had the highest effect, only the extract of Reference Example 1 will be mentioned in the following test examples for verifying the effects of the Scrophularia buergeriana Miq. extract and Poria cocos Wolf extract of the present invention. In addition, the effects of the extracts of Reference Examples 2 to 6 were generally lower than the extract of Reference Example 1 by about 10-50%, the scope of the present invention encompasses all the extracts of Reference Examples 1 to 6.
- 200 g of each of freeze-dried Scrophularia buergeriana Miq. and Poria cocos Wolf (purchased from Kunwha Pharmaceutical Co., Ltd., Korea) was crushed, and a 10-fold weight of water was added thereto. Then, the herbal materials was extracted at 80° C. for 18 hours with sufficient stirring. The extracts were cooled to room temperature and filtered through filter paper, and each of the filtrates was added to 4 kg of ethanol and left to stand for 48 hours. Then, the solutions were filtered, and each of the formed precipitates was dissolved in 2 kg of distilled water and then filtered again. The resulting filtrate was concentrated in a vacuum evaporator, thus obtaining water extracts of Scrophularia buergeriana Miq. and Poria cocos Wolf.
- 200 g of each of freeze-dried Scrophularia buergeriana Miq. and Poria cocos Wolf was added to a 10-fold weight of 70% ethanol and heated at 80° C. for 2 hours to extract effective components therefrom. The extracts were left to stand at room temperature for 2 days to precipitate impurities, and were then filtered through filter paper twice. The filtrates were concentrated in a vacuum evaporator, thus obtaining ethanol extracts of Scrophularia buergeriana Miq. and Poria cocos Wolf.
- 200 g of each of freeze-dried Scrophularia buergeriana Miq. and Poria cocos Wolf was added to a 10-fold weight of methanol and heated at 70° C. for 2 hours to extract effective components therefrom. The extracts were left to stand at room temperature for 2 days to precipitate impurities, and were then filtered through filter paper twice. The filtrates were concentrated in a vacuum evaporator, thus obtaining methanol extracts of Scrophularia buergeriana Miq. and Poria cocos Wolf.
- Each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts, prepared in Reference Example 3, was added to and completely suspended in a 20-fold weight of a mixed solvent of water and hexane (1:1). Then, each of the suspensions was left to stand at room temperature for 1 day to separate it into layers. Only the upper hexane layer was separated and concentrated in a vacuum evaporator, thus obtaining a hexane fraction of each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts.
- The lower water layer was added to and shaken in a 2-fold weight of an ethyl acetate solvent and was then left to stand at room temperature for one day to separate it into layers. The upper ethylacetate layer was separated and concentrated in a vacuum evaporator, thus obtaining an ethylacetate fraction of each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts.
- The lower water layer, obtained in the process of obtaining the ethylacetate fraction in Reference Example 4, was added to a 2-fold weight of butanol and treated in the same manner as in Reference Example 4, thus obtaining a butanol fraction of each of the extracts.
- Each of the water layers, obtained in Reference Example 5, was concentrated in a vacuum evaporator, thus obtaining a water fraction of each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts.
- Each of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts or each of the concentrated Scrophularia buergeriana Miq. and Poria cocos Wolf extracts was dissolved in water at a concentration of 30% (w/w), 1,3-butyleneglycol at a concentration at a concentration of 5% (w/w) or ethanol at a concentration of 10% (w/w). Each of the solutions was added to cosmetic formulations, such as skin lotion, milk lotion, essence or pack.
- In order to demonstrate the effects of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts, obtained in Reference Example 1 of the present invention, the following test was carried out. In Example 3 below, the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract were mixed with each other at a ratio of 1:1.
-
TABLE 1 Examples Components 1 2 3 Scrophularia buergeriana Miq. ∘ ∘ Poria cocos Wolf ∘ ∘ - In order to examine the cell differentiation-promoting effects of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts, tests were carried out using the following two methods: (1) a method of measuring the amount of cornified envelops (CE), formed in the differentiation of keratinocytes, using absorbance; and (2) a method of measuring the amount of cornified envelops (CE), formed in the differentiation of keratinocytes, using an isotope.
- In the first test of measuring absorbance, primarily cultured human keratinocytes were placed in a culture flask and allowed to adhere to the flask bottom. Then, the test materials shown in Table 2 below were added to the culture media at the concentrations shown in Table 2, and the cells were cultured for 5 days, until the cells reached a confluence of about 70-80%. The cells were harvested and washed with phosphate buffered saline (PBS). Then, 1 ml of 10 mM of Tris-HCl (pH 7.4), containing 2% sodium dodecyl sulfate (SDS) and 20 mM dithiothreitol (DTT), was added to the cells, which were then sonicated, boiled and centrifuged. The centrifuged precipitate was suspended again in 1 ml of PBS and measured for absorbance at 340 nm. Meanwhile, a portion of the solution after the sonication was sampled, and the protein content thereof was measured and used as a reference in the evaluation of cell differentiation. A group treated with low calcium (0.03 mM) and a group treated with high calcium (1.2 mM) were used as a negative control group and a positive control group, respectively, and the results of the test performed by adding the test materials to a low concentration of calcium are shown in Table 2 and FIG. 1.
- In the second test of measuring the amount of cornified envelops using an isotope, a primarily cultured human skin cell line was placed in a 24-well culture flask and allowed to adhere to the flask bottom. Then, 1 uCi/ml of [35S]-methionine together with the test materials shown in Table 2 was added to the culture medium at the concentrations shown in Table 2, and the cells were cultured for 2 days, until the cells reached a confluence of about 70-80%. The cells were harvested and washed with PBS (phosphate buffered saline), and then 500 μl of PBS, containing 2% SDS (sodium dodecyl sulfate) and 20 mM DTT (dithiothreitol), was added thereto, and the cell solution was pipetted. Then, 100 μl of the cell solution was dispensed into each scintillation vial, 2.5 ml of a cocktail solution was added thereto, and the radioactivity of the cell solution was measured with a liquid scintillation counter (LSC) to determine the total protein amount. Based on the determined total protein amount, the corresponding amount of each of the test materials was filtered through a 25-mm filter. Only the insoluble protein remaining on the filter was taken, and the filter itself was placed in a scintillation vial. 2.5 ml of a cocktail solution was added thereto, the filter was well dissolved, and the radioactivity of the solution was measured with a liquid scintillation counter. The measured value was divided by the above-prepared total protein amount to determine the amount of CE formed in differentiation. The measurement results are shown in Table 2 below and FIG. 2.
-
TABLE 2 Test material (water extract of Differentiation ability Differentiation ability (%) Scrophularia buergeriana Miq.) (%) of keratinocytes of human skin cell line Control groups Low Ca2+(0.03 mM) 100 100 High Ca2+(1.2 mM) 210 224 Groups treated 1.0 ppm Scrophularia 118 124 with test material buergeriana Miq. 1.0 ppm Poria cocos Wolf 118 120 1.0 ppm Scrophularia 128 136 buergeriana Miq./Poria cocos Wolf mixture - As can be seen in Table 2 above, the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts according to the present invention promoted the differentiation of both the keratinocytes and the human skin cell line. Also, it could be observed that the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more effective than the use of the Scrophularia buergeriana Miq. extract alone.
- The human skin cell line was placed in each well of a 96-well cell culture plate at a concentration of 5×104 cells/well and allowed to adhere to the bottom for 24 hours. The adhered cell line was treated with ach of the test materials, and after 2 days, the media were removed, and the cells were stored in a refrigerator at −20° C. The cells were disrupted by repeating freezing-thawing twice, and then treated with a mixture of acetone:ethanol=1:1 (v/v) and left to stand at 4° C. for 30 minutes to immobilize the cells. The, the cells were left to stand to evaporate the organic solvent and were blocked using 1% fetal bovine albumin, transglutaminase (primary antibody) and HRP (horseradish peroxidase) anti-mouse secondary antibody, and o-phenyldiamine (OPD) was added to develop the color of the cells. The expression level of transglutaminase in the cells was determined by measuring absorbance at 490 nm, and the correction of the measurement was carried out by measuring the background at 630 nm. A group treated with low calcium (0.03 mM) and a group treated with high calcium (1.2 mM) were used as a negative control group and a positive control group, respectively, and the results of the test performed by adding the test materials to a low concentration of calcium are shown in Table 3 and FIG. 3.
-
TABLE 3 Test material (water extract of Expression level (%) Scrophularia buergeriana Miq.) of transglutaminase Control groups Low Ca2+(0.03 mM) 100 High Ca2+(1.2 mM) 139 Groups treated 1.0 ppm Scrophularia 260 with test material buergeriana Miq. 1.0 ppm Poria cocos Wolf 210 1.0 ppm Scrophularia 268 buergeriana Miq./Poria cocos Wolf mixture - As can be seen in Table 3 above and FIG. 3, the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts according to the present invention showed an increase in transglutaminase expression level of more than two times that of the negative control group and showed a significant increase in transglutaminase expression level compared to the negative control group. Thus, it could be seen that the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts according to the present invention increased the expression of transglutaminase. Also, it could be seen that the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more, effective than the use of the Scrophularia buergeriana Miq. extract alone.
- In order to evaluate the effects of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts on the recovery of skin barrier function impaired due to long-term skin injury, the following test was carried out. Acetone was applied on the back of 8-10-week-old nude mice twice a day for 5 days to impair the skin barrier function. Then, the transepidermal water loss (TEWL) of the mouse skin was measured with an evaporimeter, and only test animals having a skin showing a transepidermal water loss of more than 40 g/m2/hr was applied with each of a vehicle (propyleneglycol:ethanol=7:3) and a test material containing 5 wt % of the Scrophularia buergeriana Miq. extract/Poria cocos Wolf extract mixture, at a dose of 200 μl per 5 cm2 of skin area twice a day for 3 days, while the TEWL of the mice skin was measured at a given time interval. The measurement results are shown in FIG. 4.
- As shown in FIG. 4, in the case of the group treated with the Scrophularia buergeriana Miq. extract/Poria cocos Wolf extract mixture, the impaired skin barrier function was recovered faster than that of the vehicle group. Also, during the measurement of TEWL, the skin water content was measured with a corneometer (Courage Khazaka, Germany) and, as a result, the skin water content in the group treated with the Scrophularia buergeriana Miq. extract/Poria cocos Wolf extract mixture was higher than that in the vehicle-treated group. Thus, it could be seen that, in the case of the group treated with the Scrophularia buergeriana Miq. extract/Poria cocos Wolf extract mixture, the skin water content was increased together with the recovery of impaired skin barrier function. The measurement results are shown in FIG. 5.
- In order to evaluate the effects of the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts on an increase in the synthesis of lipid on the human skin, the following test was carried out. The composition of the test material consisted of 0.5% of Carbopol ETD 2020, 0.45% of TEA 0.45%, 5% test material and the balance of deionized water. On the forearm of each of 12 adult men and women, a region having a size corresponding to the size of a 50-ml polypropylene conical tube was marked, and then 20 μl of each of control groups, the Scrophularia buergeriana Miq. extract and the Scrophularia buergeriana Miq. extract/Poria cocos Wolf extract mixture was applied on the subjects. Herein, the subjects were divided into two groups, lipids were extracted from the subjects at day 3 and day 11 in the following manner, and the extracted lipid were analyzed. Specifically, the forearm was washed with service water, and then subjected to tape stripping one time with Scotch® 810 Magic tape. Then, 1 ml of a mixture of cyclohexane/ethanol (4:1) was added to the forearm using a 50-ml cut polypropylene conical tube as a reservoir and shaken for about 1 minute, and was then transferred into a fresh tube. Then, 1 ml of a mixture of cyclohexane/ethanol (1:1) was added again to the tube and shaken for about 1 minute, and was then transferred into a fresh tube. Then, the content in the tube was dried with nitrogen gas at 50° C. and dissolved and stored in 500 μl of chloroform:methanol=2:1. Each of the samples was dropped onto a silica gel TLC (thin layer chromatography) plate using automated TLC sampler-4 (CAMAG) and was developed with a developing solvent, having the composition ratio shown in Table 4 below, using AMD (automated multiple development).
-
TABLE 4 Solvent Acetic Diethyl Petroleum migration Chloroform Methanol water acid Hexane ether ether distance (cm) First 40 10 1 3.0 Second 190 9 1 6.5 Third 2 12 3 7.5 Fourth 100 Top - After the TLC plate was developed, the size of each band was measured at a wavelength of 570 nm using a TLC Scanner-II densitometer (CAMAG). The production of ceramide in each treated group relative to the production of ceramide in the untreated group taken as 100% is shown in Table 5 and FIG. 6.
-
TABLE 5 Test material (water extract of 3 days after 11 days after Scrophularia buergeriana Miq.) treatment treatment Control groups Untreated group 100 100 Vehicle 103 98 Glycerin (5%) 102 94 Groups treated Scrophularia 114 125 with test group buergeriana Miq. (5%) Poria cocos Wolf (5%) 112 121 Scrophularia 121 134 buergeriana Miq./Poria cocos Wolf mixture (5%) - As shown in Table 5 and FIG. 6, at 3 days and 11 days after treatment, the groups treated with each of the Scrophularia buergeriana Miq. extract, the Poria cocos Wolf extract and the Scrophularia buergeriana Miq. extract/Poria cocos Wolf extract mixture showed an increase in the production of ceramide compared to the groups treated with the negative control groups (untreated group/vehicle) and the positive control group (glycerin). This demonstrates that the Scrophularia buergeriana Miq. and Poria cocos Wolf extracts increased the production of ceramide. Also, it could be seen that the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more effective than the use of the Scrophularia buergeriana Miq. extract alone.
- Monkey kidney epithelial cell line CV-1 (ATCC CCL 70) was subcultured in a DMEM (Dulbecco's Modified Eagle Medium) containing charcol/dextran-treated 10% fetal bovine serum. A phenol red-free medium was used to avoid the effect of estrogen upon phenol red. As plasmids, used were plasmids having PPRE (PPARs responsive element) as a promoter, followed by firefly luciferase genes as a reporter, the PPRE being activated by PPAR- (gene-containing PPAR- and ligand-bound PPAR-) bound next to the universal promoter expressed under general culture conditions, and a reference plasmid to which renilla luciferase genes were bound.
- CV-I cells were plated on a 24-well microtiter plate at a concentration of 5×104 cells per well and cultured for 24 hours. Then, the above three types of plasmid genes were subjected to transient transfection. After 24 hours of culture, the plate was washed with 1×PBS (Phosphate Buffered Saline) and treated with ligand candidates at various concentrations. After 24 hours of further culture, the plate was washed with 1×PBS and the cells were lyzed with 1×PLB (Passive Lysis Buffer) and measured for luciferase activity using the Dual-Luciferase® Reporter Assay System kit.
- In this experiment, the positive control was Wy-14,643 which was known to be the most potent PPAR-α ligand, and the negative controls were ethanol, which was used to dissolve the samples, and an untreated group. The results are shown in FIG. 7. As shown in FIG. 7, the use of the mixture of the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract was more effective in activating PPAR-α than the use of the Scrophularia buergeriana Miq. extract alone.
- From the above results, the Scrophularia buergeriana Miq. extract and the Poria cocos Wolf extract showed very effects on the promotion of skin cell differentiation, the inhibition of skin cell proliferation, the proliferation of keratinocytes, the recovery of impaired skin barrier function and the increase in skin-moisturizing capacity.
- Hereinafter, formulation examples of the inventive composition will be described, but these formulation examples are illustrative only, and the scope of the present invention is not limited thereto.
- The herbal medicinal extract in the formulation examples is any one of the extracts of Examples 1 to 3.
- Herbal medicinal extract: 1.00(%)
- Oil and fat: suitable amount
- Sodium hydroxide: q.s.
- Sodium chloride: q.s.
- Perfume: small amount
- The total amount was made 100% with purified water.
- Soap was prepared according to the above composition ration.
- Herbal medicinal extract: 3.00(%)
- L-ascorbic acid-2-magnesium phosphate: 1.00
- Water soluble collagen (1% aqueous solution): 1.00
- Sodium citrate: 0.10
- Citric acid: 0.05
- Licorice root extract: 0.20
- 1,3-butylene glycol: 3.00
- The total amount was made 100% with purified water.
- Lotion was prepared according to the above composition ratio (%).
- Herbal medicinal extract: 1.00(%)
- Polyethyleneglycol monostearate: 2.00
- Self-emulsified glycerin monostearate: 5.00
- Cetyl alcohol: 4.00
- Squalene: 6.00
- Tri-2-glyceryl ethylhexanoate: 6.00
- Glycosphingolipid: 1.00
- 1,3-butylene glycol: 7.00
- The total amount was made 100% with purified water.
- Cream was prepared according to the above composition ratio (%).
- Herbal medicinal extract: 5.00(%)
- Polyvinyl alcohol: 13.00
- L-ascorbic acid-2-magnesium sulfate: 1.00
- Lauroyl hydroxyproline: 1.00
- Water-soluble collagen (1% aqueous solution): 2.00
- 1,3-butylen glycol: 3.00
- Ethanol: 5.00
- The total amount was made 100% with purified water.
- Cosmetic pack was prepared according to the above composition ratio (%).
- Herbal medicinal extract: 2.00(%)
- Hydroxyethylene cellulose (2% aqueous solution): 12.00
- Xanthan gum (2% aqueous solution): 2.00
- 1,3-butylene glycol: 6.00
- Concentrated glycerin: 4.00
- Sodium hyaluronate (1% aqueous solution): 5.00
- The total amount was made 100% with purified water.
- Beauty solution was prepared according to the above composition ratio (%).
- As described above, the composition of the present invention can normally restore and maintain the differentiation of skin keratinocytes, and thus can prevent or alleviate dry skin symptoms, atopic symptoms and contact dermatitis, which occur due to incomplete epidermal differentiation.
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2007-0020263 | 2007-02-28 | ||
KR1020070020263A KR101352363B1 (en) | 2007-02-28 | 2007-02-28 | Composition of skin external application for moisturizing comprising Scrophularia buergeriana Miq. extract |
PCT/KR2007/004556 WO2008105579A1 (en) | 2007-02-28 | 2007-09-19 | External composition for skin containing scrophularia buergeriana miq. extract and the use thereof for the skin moisturizing cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
US20100068310A1 true US20100068310A1 (en) | 2010-03-18 |
US8168197B2 US8168197B2 (en) | 2012-05-01 |
Family
ID=39721394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/528,774 Active US8168197B2 (en) | 2007-02-28 | 2007-09-19 | External composition for skin containing Scrophularia buergeriana miq. extract and the use thereof for the skin moisturizing cosmetics |
Country Status (5)
Country | Link |
---|---|
US (1) | US8168197B2 (en) |
JP (1) | JP2010520232A (en) |
KR (1) | KR101352363B1 (en) |
CN (1) | CN101621986A (en) |
WO (1) | WO2008105579A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9949918B2 (en) | 2011-11-30 | 2018-04-24 | IBR—Israeli Biotechnology Research Ltd. | Jojoba extract useful in improving skin barrier functions |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101031614B1 (en) * | 2008-12-22 | 2011-04-27 | (주)자미원바이오텍 | Methods for Preparing Poria cocos Extracts |
CN105496831B (en) * | 2014-09-25 | 2021-08-03 | 伽蓝(集团)股份有限公司 | Composition containing extract of centella asiatica, use thereof and external preparation for skin |
KR102561147B1 (en) * | 2016-06-03 | 2023-07-27 | 주식회사 엘지생활건강 | Composition for improving skin condition comprising herb extracts mixture |
TWI640317B (en) * | 2016-09-06 | 2018-11-11 | 杏輝藥品工業股份有限公司 | Uses ofporia cocosextract and its active ingredients in protecting skin and/or promoting wound healing |
CN109549861B (en) * | 2019-01-16 | 2021-07-02 | 广州市美夫兰化妆品有限公司 | Oligopeptide-containing skin repair freeze-dried powder |
KR102285762B1 (en) * | 2020-12-15 | 2021-08-05 | 애경산업(주) | Skin cosmetic composition comprising tartaric acid |
CN113750025A (en) * | 2021-10-21 | 2021-12-07 | 上海铮信生物科技股份有限公司 | Plant composition with anti-aging effect and application of plant composition in cosmetics |
KR102503612B1 (en) * | 2021-12-17 | 2023-02-24 | 애경산업(주) | Skin external composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6078910A (en) * | 1983-10-04 | 1985-05-04 | Kanebo Ltd | Skin cosmetic |
FR2708466B1 (en) * | 1993-06-30 | 1995-10-27 | Lvmh Rech | Use of an extract of Poria cocos Wolf mushrooms for the preparation of a cosmetic or pharmaceutical composition, in particular dermatological for the treatment of acne or oily skin. |
JPH11158042A (en) * | 1997-12-03 | 1999-06-15 | Pola Chem Ind Inc | Trichogen |
JPH11199463A (en) * | 1998-01-06 | 1999-07-27 | Pola Chem Ind Inc | Skin cosmetic |
JP3667291B2 (en) * | 2002-03-08 | 2005-07-06 | 株式会社ノエビア | Topical skin preparation |
KR100491429B1 (en) * | 2002-04-01 | 2005-05-25 | 퓨리메드 주식회사 | Mixture of herbal extracts for memory enhancement |
KR100535266B1 (en) | 2003-02-18 | 2005-12-08 | 학교법인 한림대학교 | Scrophularia buergeriana extract with anti-aging activity and a composition containing the extract |
KR20040074697A (en) * | 2003-02-18 | 2004-08-26 | 학교법인 한림대학교 | Scrophularia buergeriana extract with preventing or improving activity of skin wrinkle and a composition containing the extract |
JP4179971B2 (en) | 2003-11-17 | 2008-11-12 | 小川香料株式会社 | Moisturizing plant extract and external preparation, cosmetic, bath preparation and detergent containing the extract |
JP3839438B2 (en) * | 2004-02-17 | 2006-11-01 | 徳雄 陳 | Atopic disease prevention / treatment agent |
-
2007
- 2007-02-28 KR KR1020070020263A patent/KR101352363B1/en active IP Right Grant
- 2007-09-19 WO PCT/KR2007/004556 patent/WO2008105579A1/en active Application Filing
- 2007-09-19 US US12/528,774 patent/US8168197B2/en active Active
- 2007-09-19 JP JP2009551948A patent/JP2010520232A/en active Pending
- 2007-09-19 CN CN200780051804A patent/CN101621986A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9949918B2 (en) | 2011-11-30 | 2018-04-24 | IBR—Israeli Biotechnology Research Ltd. | Jojoba extract useful in improving skin barrier functions |
Also Published As
Publication number | Publication date |
---|---|
JP2010520232A (en) | 2010-06-10 |
WO2008105579A1 (en) | 2008-09-04 |
CN101621986A (en) | 2010-01-06 |
KR101352363B1 (en) | 2014-02-05 |
KR20080079802A (en) | 2008-09-02 |
US8168197B2 (en) | 2012-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8168197B2 (en) | External composition for skin containing Scrophularia buergeriana miq. extract and the use thereof for the skin moisturizing cosmetics | |
US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
US20110085996A1 (en) | External preparation composition for skin comprising ginseng flower or ginseng seed extracts | |
US20130101689A1 (en) | Composition containing paper mulberry extracts | |
JP7309620B2 (en) | Use of an extract of pericarp of NEPHELIUM LAPPACEUM for hydrating skin and/or mucous membranes | |
JP2000511942A (en) | Use of petroselinic acid for the treatment of inflammation | |
KR20040068986A (en) | Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor | |
JP2001288066A (en) | Skin barrier function ameliorator | |
US20120065159A1 (en) | Composition containing chamaecyparis obtusa polysaccharides to be externally applied to the skin | |
US6193975B1 (en) | Use of potentilla erecta extract in the cosmetic and pharmaceutical field | |
KR101860109B1 (en) | Skin external composition containing floral ginsenoside | |
KR101917645B1 (en) | Cosmetic composition comprising saccharomyces ferment filtrate, asparagus officinalis stem extract and tussilago farfara flower extract | |
EP2735304A2 (en) | Composition for preventing or alleviating skin wrinkles containing honeybush extract or a fermented liquor thereof as an active ingredient | |
JP2008088075A (en) | Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method | |
CN116459172A (en) | Anti-glycation application of vitexin | |
US20150104426A1 (en) | Skin-care agent containing pleurotus ferulae fruit body extract or pleurotus ferulae mycelium extract | |
KR20140079571A (en) | Composition for External Application to the Skin Using an Extract of Pachyrhizus erosus | |
KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
KR101954632B1 (en) | External composition for skin containing germinated seeds of ginseng extract | |
KR102034436B1 (en) | Composition For Treating And Preventing Atopic Dermatitis Comprising Ternstroemia kwangtungensis Merr. Extracts | |
KR20160020038A (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
JPH09263526A (en) | Cosmetic composition and medicinal composition containing extract of a plant in selaginella | |
KR101877803B1 (en) | Skin external composition containing floral ginsenoside | |
KR20010057429A (en) | Skin care composition containing Ursolic acid | |
KR101791488B1 (en) | Composition of skin external application for alleviating stimulation caused from ultraviolet ray containing Oldenlandia Diffusa Willd extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AMOREPACIFIC CORPORATION,KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KIM, HAN SUNG;LEE, CHAN WOO;KIM, YOUN JOON;AND OTHERS;REEL/FRAME:023353/0427 Effective date: 20090916 Owner name: AMOREPACIFIC CORPORATION, KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KIM, HAN SUNG;LEE, CHAN WOO;KIM, YOUN JOON;AND OTHERS;REEL/FRAME:023353/0427 Effective date: 20090916 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |